Pharmacological interventions such as acetylcholinesterase inhibitors (AChEIs) and memantine have been shown to improve cognitive function and global function in patients with Alzheimer’s disease (AD) and other subtypes of dementia (6). This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.